AQST
Price
$3.57
Change
+$0.16 (+4.69%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
383.26M
68 days until earnings call
CRDL
Price
$1.38
Change
-$0.07 (-4.83%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
124.33M
74 days until earnings call
Interact to see
Advertisement

AQST vs CRDL

Header iconAQST vs CRDL Comparison
Open Charts AQST vs CRDLBanner chart's image
Aquestive Therapeutics
Price$3.57
Change+$0.16 (+4.69%)
Volume$7.67K
Capitalization383.26M
Cardiol Therapeutics
Price$1.38
Change-$0.07 (-4.83%)
VolumeN/A
Capitalization124.33M
AQST vs CRDL Comparison Chart
Loading...
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AQST vs. CRDL commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AQST is a StrongBuy and CRDL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (AQST: $3.57 vs. CRDL: $1.38)
Brand notoriety: AQST and CRDL are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AQST: 138% vs. CRDL: 263%
Market capitalization -- AQST: $383.26M vs. CRDL: $124.33M
AQST [@Pharmaceuticals: Other] is valued at $383.26M. CRDL’s [@Pharmaceuticals: Other] market capitalization is $124.33M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AQST’s FA Score shows that 0 FA rating(s) are green whileCRDL’s FA Score has 0 green FA rating(s).

  • AQST’s FA Score: 0 green, 5 red.
  • CRDL’s FA Score: 0 green, 5 red.
According to our system of comparison, AQST is a better buy in the long-term than CRDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AQST’s TA Score shows that 4 TA indicator(s) are bullish while CRDL’s TA Score has 5 bullish TA indicator(s).

  • AQST’s TA Score: 4 bullish, 5 bearish.
  • CRDL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CRDL is a better buy in the short-term than AQST.

Price Growth

AQST (@Pharmaceuticals: Other) experienced а +27.96% price change this week, while CRDL (@Pharmaceuticals: Other) price change was +10.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.45%. For the same industry, the average monthly price growth was +14.82%, and the average quarterly price growth was +63.61%.

Reported Earning Dates

AQST is expected to report earnings on Aug 12, 2025.

CRDL is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AQST($383M) has a higher market cap than CRDL($124M). CRDL YTD gains are higher at: 13.281 vs. AQST (-4.213). AQST has higher annual earnings (EBITDA): 1.18M vs. CRDL (-30.61M). CRDL has more cash in the bank: 40.5M vs. AQST (23.9M). CRDL has less debt than AQST: CRDL (181K) vs AQST (33.3M). AQST has higher revenues than CRDL: AQST (50.6M) vs CRDL (0).
AQSTCRDLAQST / CRDL
Capitalization383M124M309%
EBITDA1.18M-30.61M-4%
Gain YTD-4.21313.281-32%
P/E RatioN/AN/A-
Revenue50.6M0-
Total Cash23.9M40.5M59%
Total Debt33.3M181K18,398%
FUNDAMENTALS RATINGS
AQST vs CRDL: Fundamental Ratings
AQST
CRDL
OUTLOOK RATING
1..100
1924
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
97
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
5354
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AQST's Valuation (39) in the Pharmaceuticals Major industry is somewhat better than the same rating for CRDL (97) in the null industry. This means that AQST’s stock grew somewhat faster than CRDL’s over the last 12 months.

AQST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as CRDL (100) in the null industry. This means that AQST’s stock grew similarly to CRDL’s over the last 12 months.

CRDL's SMR Rating (96) in the null industry is in the same range as AQST (100) in the Pharmaceuticals Major industry. This means that CRDL’s stock grew similarly to AQST’s over the last 12 months.

AQST's Price Growth Rating (53) in the Pharmaceuticals Major industry is in the same range as CRDL (54) in the null industry. This means that AQST’s stock grew similarly to CRDL’s over the last 12 months.

AQST's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as CRDL (100) in the null industry. This means that AQST’s stock grew similarly to CRDL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AQSTCRDL
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RHHBY40.800.82
+2.05%
Roche Holding Ltd
WLBMF0.04N/A
+1.62%
Wallbridge Mining Company Ltd.
EONGY17.600.11
+0.63%
E.ON SE
SOMLY9.180.01
+0.05%
Secom Co., Ltd.
BMRRY15.39-2.53
-14.09%
B&M European Value Retail SA

AQST and

Correlation & Price change

A.I.dvisor indicates that over the last year, AQST has been loosely correlated with SCYX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AQST jumps, then SCYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AQST
1D Price
Change %
AQST100%
+7.23%
SCYX - AQST
36%
Loosely correlated
+6.25%
OGI - AQST
32%
Poorly correlated
+0.75%
EOLS - AQST
31%
Poorly correlated
-1.61%
TLRY - AQST
30%
Poorly correlated
+2.17%
DERM - AQST
30%
Poorly correlated
+3.47%
More

CRDL and

Correlation & Price change

A.I.dvisor tells us that CRDL and KMDA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
+10.69%
KMDA - CRDL
30%
Poorly correlated
-1.04%
ACB - CRDL
30%
Poorly correlated
+3.72%
AQST - CRDL
28%
Poorly correlated
+7.23%
OGI - CRDL
28%
Poorly correlated
+0.75%
CGC - CRDL
28%
Poorly correlated
+7.44%
More